Suchergebnisse - "Avirutnan, Panisadee"

PubPharm (56)

1

A randomized trial to assess the acceleration of viral clearance by the combination Favipiravir/Ivermectin/Niclosamide in mild-to-moderate COVID-19 adult patients (FINCOV)

enthalten in: Journal of infection and public health | 2024

von Siripongboonsitti, T. | Tawinprai, K. | Avirutnan, P. | +2

2

Heterologous prime-boost immunization induces protection against dengue virus infection in cynomolgus macaques

enthalten in: Journal of virology | 2023

von Keelapang, P. | Ketloy, C. | Puttikhunt, C. | +21

3

Dengue virus NS1 secretion is regulated via importin-subunit β1 controlling expression of the chaperone GRp78 and targeted by the clinical drug ivermectin

enthalten in: mBio | 2023

von Denolly, S. | Guo, H. | Martens, M. | +10

4

Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022

enthalten in: Immunotherapy advances | 2023

von Barnes, M. | Mandla, A. | Smith, E. | +38

5

Analytical and diagnostic performance characteristics of reverse-transcriptase loop-mediated isothermal amplification assays for dengue virus serotypes 1-4 : A scoping review to inform potential use in portable molecular diagnostic devices

enthalten in: PLOS global public health | 2023

von Arkell, P. | Mairiang, D. | Songjaeng, A. | +6

6

Treatments for dengue : a Global Dengue Alliance to address unmet needs

enthalten in: The Lancet. Global health | 2023

von Dengue Alliance. Electronic address: gnmalavige@dndi.org | Dengue Alliance | Anasir, M. | +56

7

Differential critical residues on the overlapped region of the non-structural protein-1 recognized by flavivirus and dengue virus cross-reactive monoclonal antibodies

enthalten in: Scientific reports | 2022

von Luangaram, P. | Tamdet, C. | Saengwong, C. | +9

8

Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations

enthalten in: BMC pharmacology & toxicology | 2022

von Jitobaom, K. | Boonarkart, C. | Manopwisedjaroen, S. | +5

9

Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations

enthalten in: BMC pharmacology & toxicology | 2022

von Jitobaom, K. | Boonarkart, C. | Manopwisedjaroen, S. | +5

10

Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations

enthalten in: BMC pharmacology & toxicology | 2022

von Jitobaom, K. | Boonarkart, C. | Manopwisedjaroen, S. | +5

1
2
3
4
5
6
Nächster »
[6]